{"schema_version":"1","generated_at":"2026-11-03T16:44:26.227Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ashwin-somasundaram","json_url":"https://www.findmykol.com/kol/ashwin-somasundaram/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ashwin-somasundaram","name":"Ashwin Somasundaram","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Pittsburgh","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1356784763","orcid":"0000-0003-3167-406X","openalex":"A5063843417"},"summary":"Ashwin Somasundaram is an Oncology physician. OpenAlex indexes 67 publications with 1,652 citations (h-index 18); ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":67,"cited_by_count":1652,"h_index":18,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06483555","title":"Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06483555","trial_url":"https://www.findmykol.com/trial/NCT06483555"},{"nct":"NCT06158139","title":"Autologous CAR-T Cells Targeting B7-H3 in PDAC","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06158139","trial_url":"https://www.findmykol.com/trial/NCT06158139"},{"nct":"NCT03977233","title":"Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03977233","trial_url":"https://www.findmykol.com/trial/NCT03977233"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Caris MPI, Inc.","program_year":2025,"amount_usd":130.28,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356784763"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":68.49,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356784763"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":114.05,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356784763"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1356784763","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":37.3,"classes_total":5,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":18.4,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":46},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":7.8,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":35.1,"classes_total":3,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":17.3,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":39},{"class":"Other antidepressants","setting":"prescribed","share_pct":10.5,"drugs":[{"name":"Mirtazapine","share_pct":100}],"max_beneficiaries":16}]},{"area":"Sensory organs","share_pct":17.3,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":17.3,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":27}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":7.9,"facility_pct":92.1},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Latent Regulatory Programs Generate Synthetic T Cell States with Enhanced Therapeutic Potential","year":2026,"journal":"bioRxiv (Cold Spring Harbor Laboratory)","source_url":"https://doi.org/10.64898/2026.01.07.698190","status":"verified"},{"title":"KRAS: the Achilles’ heel of pancreas cancer biology","year":2025,"journal":"Journal of Clinical Investigation","source_url":"https://doi.org/10.1172/jci191939","status":"verified"},{"title":"Dysfunctional CD11c <sup>−</sup> CD21 <sup>−</sup> extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer","year":2025,"journal":"Science Translational Medicine","source_url":"https://doi.org/10.1126/scitranslmed.adh1315","status":"verified"},{"title":"Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer","year":2025,"journal":"JCO Precision Oncology","source_url":"https://doi.org/10.1200/po-25-00332","status":"verified"},{"title":"Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With <i>KRAS</i> / <i>NRAS</i> / <i>BRAF</i> Wild-Type Microsatellite Stable Metastatic Colorectal Cancer","year":2025,"journal":"JCO oncology advances.","source_url":"https://doi.org/10.1200/oa-24-00086","status":"verified"}],"source":"works"},"contact":{"address_1":"200 LOTHROP ST","address_2":"SUITE N-715","city":"Pittsburgh","state":"PA","zip":"152132536","phone":"412-692-4700","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1356784763","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":2,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-12-07","provider_certified":"2021-12-07","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}